table of content
1 Introduction to Research & Analysis Reports
1.1 Human Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Gene Therapy Overall Market Size
2.1 Global Human Gene Therapy Market Size: 2022 VS 2029
2.2 Global Human Gene Therapy Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Gene Therapy Sales: 2018-2029
3 Company Landscape
3.1 Top Human Gene Therapy Players in Global Market
3.2 Top Global Human Gene Therapy Companies Ranked by Revenue
3.3 Global Human Gene Therapy Revenue by Companies
3.4 Global Human Gene Therapy Sales by Companies
3.5 Global Human Gene Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Gene Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Gene Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Gene Therapy Players in Global Market
3.8.1 List of Global Tier 1 Human Gene Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Gene Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Gene Therapy Market Size Markets, 2022 & 2029
4.1.2 Non-viral Vectors
4.1.3 Viral Vectors
4.2 By Type - Global Human Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Human Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Human Gene Therapy Revenue, 2024-2029
4.2.3 By Type - Global Human Gene Therapy Revenue Market Share, 2018-2029
4.3 By Type - Global Human Gene Therapy Sales & Forecasts
4.3.1 By Type - Global Human Gene Therapy Sales, 2018-2023
4.3.2 By Type - Global Human Gene Therapy Sales, 2024-2029
4.3.3 By Type - Global Human Gene Therapy Sales Market Share, 2018-2029
4.4 By Type - Global Human Gene Therapy Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Gene Therapy Market Size, 2022 & 2029
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 DMD (Duchenne Muscular Dystrophy)
5.1.5 Hepatological Diseases
5.1.6 Others
5.2 By Application - Global Human Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Human Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Human Gene Therapy Revenue, 2024-2029
5.2.3 By Application - Global Human Gene Therapy Revenue Market Share, 2018-2029
5.3 By Application - Global Human Gene Therapy Sales & Forecasts
5.3.1 By Application - Global Human Gene Therapy Sales, 2018-2023
5.3.2 By Application - Global Human Gene Therapy Sales, 2024-2029
5.3.3 By Application - Global Human Gene Therapy Sales Market Share, 2018-2029
5.4 By Application - Global Human Gene Therapy Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Human Gene Therapy Market Size, 2022 & 2029
6.2 By Region - Global Human Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Human Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Human Gene Therapy Revenue, 2024-2029
6.2.3 By Region - Global Human Gene Therapy Revenue Market Share, 2018-2029
6.3 By Region - Global Human Gene Therapy Sales & Forecasts
6.3.1 By Region - Global Human Gene Therapy Sales, 2018-2023
6.3.2 By Region - Global Human Gene Therapy Sales, 2024-2029
6.3.3 By Region - Global Human Gene Therapy Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Human Gene Therapy Revenue, 2018-2029
6.4.2 By Country - North America Human Gene Therapy Sales, 2018-2029
6.4.3 US Human Gene Therapy Market Size, 2018-2029
6.4.4 Canada Human Gene Therapy Market Size, 2018-2029
6.4.5 Mexico Human Gene Therapy Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Human Gene Therapy Revenue, 2018-2029
6.5.2 By Country - Europe Human Gene Therapy Sales, 2018-2029
6.5.3 Germany Human Gene Therapy Market Size, 2018-2029
6.5.4 France Human Gene Therapy Market Size, 2018-2029
6.5.5 U.K. Human Gene Therapy Market Size, 2018-2029
6.5.6 Italy Human Gene Therapy Market Size, 2018-2029
6.5.7 Russia Human Gene Therapy Market Size, 2018-2029
6.5.8 Nordic Countries Human Gene Therapy Market Size, 2018-2029
6.5.9 Benelux Human Gene Therapy Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Human Gene Therapy Revenue, 2018-2029
6.6.2 By Region - Asia Human Gene Therapy Sales, 2018-2029
6.6.3 China Human Gene Therapy Market Size, 2018-2029
6.6.4 Japan Human Gene Therapy Market Size, 2018-2029
6.6.5 South Korea Human Gene Therapy Market Size, 2018-2029
6.6.6 Southeast Asia Human Gene Therapy Market Size, 2018-2029
6.6.7 India Human Gene Therapy Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Human Gene Therapy Revenue, 2018-2029
6.7.2 By Country - South America Human Gene Therapy Sales, 2018-2029
6.7.3 Brazil Human Gene Therapy Market Size, 2018-2029
6.7.4 Argentina Human Gene Therapy Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Gene Therapy Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Human Gene Therapy Sales, 2018-2029
6.8.3 Turkey Human Gene Therapy Market Size, 2018-2029
6.8.4 Israel Human Gene Therapy Market Size, 2018-2029
6.8.5 Saudi Arabia Human Gene Therapy Market Size, 2018-2029
6.8.6 UAE Human Gene Therapy Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Human Gene Therapy Major Product Offerings
7.1.4 Biogen Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.1.5 Biogen Key News & Latest Developments
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Company Summary
7.2.2 Sarepta Therapeutics Business Overview
7.2.3 Sarepta Therapeutics Human Gene Therapy Major Product Offerings
7.2.4 Sarepta Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.2.5 Sarepta Therapeutics Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Human Gene Therapy Major Product Offerings
7.3.4 Gilead Sciences Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Human Gene Therapy Major Product Offerings
7.4.4 Amgen Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Human Gene Therapy Major Product Offerings
7.5.4 Novartis Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Orchard Therapeutics
7.6.1 Orchard Therapeutics Company Summary
7.6.2 Orchard Therapeutics Business Overview
7.6.3 Orchard Therapeutics Human Gene Therapy Major Product Offerings
7.6.4 Orchard Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.6.5 Orchard Therapeutics Key News & Latest Developments
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Human Gene Therapy Major Product Offerings
7.7.4 Spark Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Spark Therapeutics Key News & Latest Developments
7.8 Agc Biologics
7.8.1 Agc Biologics Company Summary
7.8.2 Agc Biologics Business Overview
7.8.3 Agc Biologics Human Gene Therapy Major Product Offerings
7.8.4 Agc Biologics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Agc Biologics Key News & Latest Developments
7.9 Anges
7.9.1 Anges Company Summary
7.9.2 Anges Business Overview
7.9.3 Anges Human Gene Therapy Major Product Offerings
7.9.4 Anges Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.9.5 Anges Key News & Latest Developments
7.10 Bluebird Bio
7.10.1 Bluebird Bio Company Summary
7.10.2 Bluebird Bio Business Overview
7.10.3 Bluebird Bio Human Gene Therapy Major Product Offerings
7.10.4 Bluebird Bio Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.10.5 Bluebird Bio Key News & Latest Developments
7.11 Jazz Pharmaceuticals
7.11.1 Jazz Pharmaceuticals Company Summary
7.11.2 Jazz Pharmaceuticals Human Gene Therapy Business Overview
7.11.3 Jazz Pharmaceuticals Human Gene Therapy Major Product Offerings
7.11.4 Jazz Pharmaceuticals Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.11.5 Jazz Pharmaceuticals Key News & Latest Developments
7.12 Dynavax Technologies
7.12.1 Dynavax Technologies Company Summary
7.12.2 Dynavax Technologies Human Gene Therapy Business Overview
7.12.3 Dynavax Technologies Human Gene Therapy Major Product Offerings
7.12.4 Dynavax Technologies Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.12.5 Dynavax Technologies Key News & Latest Developments
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Company Summary
7.13.2 Human Stem Cells Institute Human Gene Therapy Business Overview
7.13.3 Human Stem Cells Institute Human Gene Therapy Major Product Offerings
7.13.4 Human Stem Cells Institute Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.13.5 Human Stem Cells Institute Key News & Latest Developments
7.14 Sibiono Genetech
7.14.1 Sibiono Genetech Company Summary
7.14.2 Sibiono Genetech Business Overview
7.14.3 Sibiono Genetech Human Gene Therapy Major Product Offerings
7.14.4 Sibiono Genetech Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.14.5 Sibiono Genetech Key News & Latest Developments
7.15 Shanghai Sunway Biotech
7.15.1 Shanghai Sunway Biotech Company Summary
7.15.2 Shanghai Sunway Biotech Business Overview
7.15.3 Shanghai Sunway Biotech Human Gene Therapy Major Product Offerings
7.15.4 Shanghai Sunway Biotech Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.15.5 Shanghai Sunway Biotech Key News & Latest Developments
7.16 Uniqure N.V.
7.16.1 Uniqure N.V. Company Summary
7.16.2 Uniqure N.V. Business Overview
7.16.3 Uniqure N.V. Human Gene Therapy Major Product Offerings
7.16.4 Uniqure N.V. Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.16.5 Uniqure N.V. Key News & Latest Developments
7.17 Gensight Biologics S.A.
7.17.1 Gensight Biologics S.A. Company Summary
7.17.2 Gensight Biologics S.A. Business Overview
7.17.3 Gensight Biologics S.A. Human Gene Therapy Major Product Offerings
7.17.4 Gensight Biologics S.A. Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.17.5 Gensight Biologics S.A. Key News & Latest Developments
7.18 Celgene Corporation
7.18.1 Celgene Corporation Company Summary
7.18.2 Celgene Corporation Business Overview
7.18.3 Celgene Corporation Human Gene Therapy Major Product Offerings
7.18.4 Celgene Corporation Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.18.5 Celgene Corporation Key News & Latest Developments
7.19 Cellectis
7.19.1 Cellectis Company Summary
7.19.2 Cellectis Business Overview
7.19.3 Cellectis Human Gene Therapy Major Product Offerings
7.19.4 Cellectis Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.19.5 Cellectis Key News & Latest Developments
7.20 Sangamo Therapeutics
7.20.1 Sangamo Therapeutics Company Summary
7.20.2 Sangamo Therapeutics Business Overview
7.20.3 Sangamo Therapeutics Human Gene Therapy Major Product Offerings
7.20.4 Sangamo Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.20.5 Sangamo Therapeutics Key News & Latest Developments
7.21 Mustang Bio
7.21.1 Mustang Bio Company Summary
7.21.2 Mustang Bio Business Overview
7.21.3 Mustang Bio Human Gene Therapy Major Product Offerings
7.21.4 Mustang Bio Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.21.5 Mustang Bio Key News & Latest Developments
7.22 AGTC
7.22.1 AGTC Company Summary
7.22.2 AGTC Business Overview
7.22.3 AGTC Human Gene Therapy Major Product Offerings
7.22.4 AGTC Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.22.5 AGTC Key News & Latest Developments
7.23 Poseida Therapeutics
7.23.1 Poseida Therapeutics Company Summary
7.23.2 Poseida Therapeutics Business Overview
7.23.3 Poseida Therapeutics Human Gene Therapy Major Product Offerings
7.23.4 Poseida Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.23.5 Poseida Therapeutics Key News & Latest Developments
8 Global Human Gene Therapy Production Capacity, Analysis
8.1 Global Human Gene Therapy Production Capacity, 2018-2029
8.2 Human Gene Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Gene Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Gene Therapy Supply Chain Analysis
10.1 Human Gene Therapy Industry Value Chain
10.2 Human Gene Therapy Upstream Market
10.3 Human Gene Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Gene Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
